Id |
Subject |
Object |
Predicate |
Lexical cue |
T774 |
49-59 |
SP_7 |
denotes |
SARS-CoV-2 |
T775 |
137-143 |
UBERON:0002405 |
denotes |
immune |
T776 |
144-157 |
GO:0065007 |
denotes |
dysregulation |
T10521 |
146-156 |
SP_7 |
denotes |
sregulatio |
T777 |
233-239 |
UBERON:0002405;GO:0006955 |
denotes |
immune |
T75385 |
234-240 |
UBERON:0002405 |
denotes |
mmune |
T778 |
240-253 |
GO:0065007 |
denotes |
dysregulation |
T74786 |
241-254 |
GO:0065007 |
denotes |
ysregulation |
T779 |
289-293 |
PR:000001393 |
denotes |
IL-6 |
T780 |
305-310 |
PR:000001136 |
denotes |
IL-1β |
T82585 |
330-335 |
UBERON:0002405;GO:0006955 |
denotes |
drive |
T80560 |
336-349 |
GO:0065007 |
denotes |
by IL-1β. Th |
T781 |
340-345 |
PR:000001136 |
denotes |
IL-1β |
T782 |
382-388 |
UBERON:0002405 |
denotes |
immune |
T1347 |
386-390 |
PR:000001393 |
denotes |
ne d |
T783 |
389-402 |
GO:0065007 |
denotes |
dysregulation |
T32757 |
402-407 |
PR:000001136 |
denotes |
: ove |
T18461 |
437-442 |
PR:000001136 |
denotes |
ry cy |
T784 |
453-462 |
CL:0000576 |
denotes |
monocytes |
T785 |
467-480 |
GO:0065007 |
denotes |
dysregulation |
T99196 |
479-484 |
UBERON:0002405 |
denotes |
n of |
T786 |
484-495 |
CL:0000542 |
denotes |
lymphocytes |
T99785 |
485-498 |
GO:0065007 |
denotes |
ymphocytes ch |
T787 |
513-516 |
PR:000001004 |
denotes |
CD4 |
T788 |
546-552 |
CL:0000236 |
denotes |
B cell |
T92525 |
549-558 |
CL:0000576 |
denotes |
ell lymph |
T72870 |
563-576 |
GO:0065007 |
denotes |
a. In paralle |
T1208 |
580-591 |
CL:0000542 |
denotes |
he absolute |
T789 |
592-606 |
CL:0000623 |
denotes |
natural killer |
T790 |
608-610 |
CL:0000623 |
denotes |
NK |
T5277 |
609-612 |
PR:000001004 |
denotes |
K) |
T61893 |
642-648 |
CL:0000236 |
denotes |
ly as |
T791 |
682-687 |
NCBITaxon:10239 |
denotes |
virus |
T62153 |
689-703 |
CL:0000623 |
denotes |
It was previou |
T87095 |
705-707 |
CL:0000623 |
denotes |
y |
T792 |
734-738 |
PR:000001393 |
denotes |
IL-6 |
T793 |
771-780 |
GO:0030425;CL:0000451 |
denotes |
dendritic |
T20268 |
778-783 |
NCBITaxon:10239 |
denotes |
ic ce |
T794 |
781-786 |
CL:0000451 |
denotes |
cells |
T795 |
798-801 |
PR:000029150 |
denotes |
HLA |
T796 |
805-813 |
GO:0016020 |
denotes |
membrane |
T797 |
814-824 |
GO:0010467 |
denotes |
expression |
T75279 |
831-835 |
PR:000001393 |
denotes |
crea |
T798 |
857-862 |
PR:000000017 |
denotes |
IFN-γ |
T56430 |
868-877 |
GO:0030425;CL:0000451 |
denotes |
4 cells ( |
T12578 |
878-883 |
CL:0000451 |
denotes |
hno e |
T3238 |
894-897 |
PR:000029150 |
denotes |
). |
T59989 |
901-909 |
GO:0016020 |
denotes |
e findin |
T93045 |
910-920 |
GO:0010467 |
denotes |
s of our s |
T26103 |
953-958 |
PR:000000017 |
denotes |
osal |
T799 |
963-967 |
PR:000001393 |
denotes |
IL-6 |
T800 |
1003-1006 |
PR:000029150 |
denotes |
HLA |
T801 |
1017-1021 |
PR:000001889 |
denotes |
CD14 |
T802 |
1022-1031 |
CL:0000576 |
denotes |
monocytes |
T803 |
1037-1041 |
PR:000001393 |
denotes |
IL-6 |
T45698 |
1059-1063 |
PR:000001393 |
denotes |
the |
T804 |
1064-1069 |
UBERON:0000178 |
denotes |
blood |
T805 |
1099-1102 |
PR:000029150 |
denotes |
HLA |
T83941 |
1099-1102 |
PR:000029150 |
denotes |
HLA |
T806 |
1106-1116 |
GO:0010467 |
denotes |
expression |
T95814 |
1113-1117 |
PR:000001889 |
denotes |
ion |
T36215 |
1118-1127 |
CL:0000576 |
denotes |
Figure 5A |
T96775 |
1133-1137 |
PR:000001393 |
denotes |
the |
T807 |
1150-1161 |
DG_35 |
denotes |
Tocilizumab |
T62865 |
1160-1165 |
UBERON:0000178 |
denotes |
b in |
T86335 |
1195-1198 |
PR:000029150 |
denotes |
cel |
T83716 |
1202-1212 |
GO:0010467 |
denotes |
artially r |
T808 |
1224-1234 |
GO:0010467 |
denotes |
expression |
T809 |
1238-1241 |
PR:000029150 |
denotes |
HLA |
T56499 |
1246-1257 |
DG_35 |
denotes |
n cell memb |
T810 |
1248-1262 |
GO:0005886 |
denotes |
cell membranes |
T811 |
1301-1311 |
CL:0000542 |
denotes |
lymphocyte |
T95871 |
1320-1330 |
GO:0010467 |
denotes |
f six pati |
T4549 |
1334-1337 |
PR:000029150 |
denotes |
in |
T2844 |
1344-1358 |
GO:0005886 |
denotes |
after Tociliz |
T812 |
1351-1362 |
DG_35 |
denotes |
Tocilizumab |
T52101 |
1397-1407 |
CL:0000542 |
denotes |
s are indi |
T29139 |
1447-1458 |
DG_35 |
denotes |
ulating HLA |
T813 |
1455-1458 |
PR:000029150 |
denotes |
HLA |
T814 |
1505-1513 |
SP_7 |
denotes |
COVID-19 |
T58538 |
1551-1554 |
PR:000029150 |
denotes |
l., |
T50203 |
1601-1609 |
SP_7 |
denotes |
ignature |
T815 |
1613-1619 |
UBERON:0002405;GO:0006955 |
denotes |
immune |
T816 |
1620-1633 |
GO:0006955 |
denotes |
dysregulation |
T817 |
1655-1665 |
SP_7 |
denotes |
SARS-CoV-2 |
T29702 |
1710-1715 |
UBERON:0002405;GO:0006955 |
denotes |
high |
T17561 |
1716-1729 |
GO:0006955 |
denotes |
ytokine produ |
T90888 |
1751-1761 |
SP_7 |
denotes |
reased cir |
T818 |
1792-1796 |
PR:000001393 |
denotes |
IL-6 |
T819 |
1872-1876 |
PR:000001393 |
denotes |
IL-6 |
T69958 |
1888-1892 |
PR:000001393 |
denotes |
crea |
T820 |
1898-1901 |
PR:000029150 |
denotes |
HLA |
T821 |
1905-1915 |
GO:0010467 |
denotes |
expression |
T56935 |
1968-1972 |
PR:000001393 |
denotes |
inic |
T72906 |
1994-1997 |
PR:000029150 |
denotes |
acy |
T21106 |
2001-2011 |
GO:0010467 |
denotes |
Anakinra, |
T822 |
2011-2020 |
DG_39 |
denotes |
Sarilumab |
T823 |
2038-2049 |
DG_35 |
denotes |
Tocilizumab |
T43307 |
2108-2117 |
DG_39 |
denotes |
298 and E |
T89983 |
2135-2146 |
DG_35 |
denotes |
-001039-29) |